| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 31,8 k € | -26.4% | 43,2 k € | +32.6% | 32,6 k € | -53.9% | 70,6 k € | +101.4% | 35,0 k € | -31.2% | 50,9 k € | +67.0% | 30,5 k € | +90.0% | 16,0 k € | +439.4% | -4,7 k € | -110.3% | 46,1 k € | +25.1% | 36,9 k € | -20.8% | 46,5 k € | +43.5% | 32,4 k € | -32.1% | 47,7 k € | +332.7% | 11,0 k € | |
| EBITDA | 30,0 k € | -27.9% | 41,7 k € | +36.4% | 30,6 k € | -55.9% | 69,3 k € | +108.4% | 33,2 k € | -30.2% | 47,6 k € | +231.1% | 14,4 k € | -2.8% | 14,8 k € | +351.6% | -5,9 k € | -113.4% | 43,9 k € | +21.4% | 36,2 k € | -21.0% | 45,8 k € | +45.7% | 31,4 k € | -30.8% | 45,4 k € | +311.6% | 11,0 k € | |
| Operating profit | 16,9 k € | -41.0% | 28,5 k € | +65.6% | 17,2 k € | -69.2% | 56,0 k € | +181.4% | 19,9 k € | -40.3% | 33,3 k € | +31733.4% | 104,7 € | +129.6% | -354,2 € | +98.2% | -20,0 k € | -167.0% | 29,8 k € | +31.3% | 22,7 k € | -38.1% | 36,7 k € | +63.3% | 22,4 k € | -38.8% | 36,7 k € | +312.4% | 8,9 k € | |
| Profit/loss | 6,0 k € | -65.2% | 17,3 k € | +477.1% | 3,0 k € | -93.8% | 48,1 k € | +526.7% | 7,7 k € | -57.8% | 18,2 k € | +253.9% | -11,8 k € | +6.0% | -12,6 k € | +62.2% | -33,3 k € | -738.2% | -4,0 k € | -186.3% | 4,6 k € | -71.4% | 16,1 k € | +310.9% | 3,9 k € | -70.6% | 13,3 k € | +1284.8% | 960,2 € | |
| Equity | 68,8 k € | +9.6% | 62,7 k € | +38.2% | 45,4 k € | +7.1% | 42,4 k € | +841.2% | -5,7 k € | +57.3% | -13,4 k € | +57.6% | -31,6 k € | -59.8% | -19,8 k € | -175.0% | -7,2 k € | -127.6% | 26,1 k € | -13.2% | 30,0 k € | -1.3% | 30,4 k € | +57.1% | 19,4 k € | -5.3% | 20,5 k € | +185.7% | 7,2 k € | |
| Total assets | 302,2 k € | -4.3% | 315,9 k € | -5.6% | 334,7 k € | -2.7% | 343,9 k € | -3.8% | 357,6 k € | -2.9% | 368,2 k € | -5.8% | 390,9 k € | -4.2% | 408,1 k € | -5.2% | 430,5 k € | -8.4% | 469,9 k € | -0.4% | 471,9 k € | +48.3% | 318,2 k € | -0.5% | 319,7 k € | -2.5% | 327,7 k € | +10.8% | 295,7 k € | |
| Cash | — | — | — | — | — | — | — | — | — | 4,4 k € | +1425.9% | 287,7 € | -96.3% | 7,7 k € | — | 5,8 k € | +99.8% | 2,9 k € | ||||||||||||
| Debts | 233,4 k € | -7.8% | 253,1 k € | -12.5% | 289,3 k € | -4.0% | 301,5 k € | -17.0% | 363,4 k € | -4.5% | 380,3 k € | -9.2% | 418,9 k € | -1.2% | 424,1 k € | -2.7% | 436,0 k € | -1.8% | 443,8 k € | +0.4% | 441,9 k € | +53.6% | 287,8 k € | -4.2% | 300,3 k € | -2.3% | 307,3 k € | +6.5% | 288,5 k € | |
Private limited company · Tournai · incorporated on 15/02/2010
Private limited company profitable and well capitalised. Cash position rising (+1425.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DEFI SOINS is a Private limited company incorporated in 2010. Its registered office is in Tournai.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette